Key result
Newly synthesized propafenone derivatives 5OCl-PF and 5OF-PF did not demonstrate better antiarrhythmic effects than the parent compound propafenone in a rat model of aconitine-induced arrhythmia.
Why the study?
It was unknown whether newly synthesized propafenone derivatives with changes in the benzyl moiety have a different antiarrhythmic effect compared to propafenone.
Newly synthesized propafenone derivatives with changes in the benzyl moiety did not demonstrate superior antiarrhythmic efficacy compared to the parent compound propafenone in a rat model.
Answers are grounded in this paper and cite their sources.
These derivatives show no antiarrhythmic advantage in rats; leaves open whether other modifications could enhance propafenone efficacy.
It is well known that the presence of different chemical groups in drug molecules influences their pharmacological properties. The aim of our study is to investigate whether newly synthesized derivatives of propafenone, with changes in benzyl moiety, have a different effect upon arrhythmia, compared to propafenone. 5OCl-PF and 5OF-PF are derivatives of propafenone with -Cl or -F substituent on the ortho position of the benzyl moiety. For verification of their antiarrhythmic effect, we used an in vivo rat model of aconitine-induced arrhythmia. 5OCl-PF speeded the appearance of supraventricular premature beats (SVPB) and death more than aconitine. All animals treated with 5OCl-PF developed ventricular premature beats in salvos (VPBS), bigeminies (VPBB) and paroxysmal ventricular tachycardia (PVT). 5OF-PF had a negative chronotropic effect and potentiated atrial excitability (more SVPB). It had a positive effect on the occurrence and onset time of supraventricular tachycardia, VPBS, and PVT. Based on the obtained results, it can be concluded that newly synthesized propafenone derivatives have no better antiarrhythmic effect than the parent compound. In the future, our research will be focused on the synthesis of different derivatives and examining their antiarrhythmic effects.
No takes yet. Share an insight, caveat, or question.
Ivković et al. (2022) studied Aconitine-induced arrhythmia (n=45). Propafenone derivatives (5OCl-PF and 5OF-PF) vs. Propafenone and Aconitine control was evaluated on Onset time of paroxysmal ventricular tachycardia (PVT) for 5OCl-PF vs Propafenone (p=<0.01). Newly synthesized propafenone derivatives 5OCl-PF and 5OF-PF did not demonstrate better antiarrhythmic effects than the parent compound propafenone in a rat model of aconitine-induced arrhythmia.
Synapse has enriched 10 related papers. Consider them for comparative context: